The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts

Journal of Cell Biology

Volumn 145, Issue 3, 1999, Pages 527-538

  Burgess, Teresa L ^a   Qian, Yi Xin ^a   Kaufman, Stephen ^a   Ring, Brian D ^a   Van, Gwyneth ^a   Capparelli, Charles ^a   Kelley, Michael ^a   Hsu, Hailing ^a   Boyle, William J ^a   Dunstan, Colin R ^a   Hu, Sylvia ^a   Lacey, David L ^a  

^a AMGEN INC   (United States)

Author keywords

Bone remodeling; Bone resorption; Hematopoietic cell growth factors; Osteoclast; Osteoporosis

Indexed keywords

INTERLEUKIN 3;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL MATURATION; COLONY FORMATION; GENE REARRANGEMENT; GENETIC ORGANIZATION; HEMATOPOIETIC CELL; HYPERCALCEMIA; LIGAND BINDING; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEM CELL;

ANIMALIA;

EID: 0033519221     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.145.3.527     Document Type: Article

References (55)

1. Abe, E., H. Tanaka, Y. Ishimi, C. Miyaura, T. Hayashi, H. Nagasawa, M. Tomida, Y. Yamaguchi, M. Hozumi, and T. Suda. 1986. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc. Natl. Acad. Sci. USA. 83:5958-5962.
2. Anderson, D.M., E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-179.
3. Arnett, T.R., and D.W. Dempster. 1986. Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology. 119:119-124.
4. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90:1622-1627.
5. Brown, M.B., and A.B. Forsythe. 1974. Robust tests for equality of variances. J. Am. Stat. Assn. 69:364-367.
6. Bucay, N., I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, and W.S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260-1268.
7. Chambers, T.J., B.M. Thomson, and K. Fuller. 1984. Effect of substrate composition on bone resorption by rabbit osteoclasts. J. Cell. Sci. 70:61-71.
8. Chellaiah, M., and K. Hruska. 1996. Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol. Biol. Cell. 7:743-753.
9. Chellaiah, M., C. Fitzgerald, U. Alvarez, and K. Hruska. 1998. c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase. J. Biol. Chem. 273:11908-11916.
10. Darnay, B.B., V. Haridas, J. Ni, P.A. Moore, and B.B. Aggarwal. 1998. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-JUN N-terminal kinase J. Biol. Chem. 273: 2055-20555.
11. Dunnett, C.W. 1955. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1096-1121.
12. Fuller, K., A.C. Gallagher, and T.J. Chambers. 1991. Osteoclast resorption: stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix. Biochem. Biophys. Res. Comm. 181:67-73.
13. Fuller, K., J.M. Owens, C.J. Jagger, A. Wilson, R. Moss, and T.J. Chambers. 1993. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 178:1733-1744.
14. Fuller, K., B. Wong, S. Fox, Y. Choi, and T.J. Chambers. 1998. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188:997-1001.
15. Hall, T.J., and T.J. Chambers. 1996. Molecular aspects of osteoclast function. Inflamm. Res. 45:1-9.
16. Hall, T.J., H. Jeker, and M. Schaueblin. 1995. Wortmannin, a potent inhibitor of phosphatidyl-inositol 3-kinase, inhibits osteoclastic bone resorption in vitro. Calcif. Tissue Int. 56:336-338.
17. Hentunen, T.A., N.S. Cunningham, O. Vuolteenaho, A.H. Reddi, and H.K. Väänänen. 1994. Osteoclast recruiting activity in bone matrix. Bone Miner. 25:183-198.
18. c-src in association with intracellular membranes. J. Cell Biol. 119:1003-1013.
19. Horton, J.E. 1972. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science. 177:793-795.
20. 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology. 136:2984-2992.
21. Hsu, H., D.L. Lacey, C.R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H.-L. Tan, G. Elliott, M.J. Kelley, I. Sarosi, et al. 1999. TNFR family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. 96:3540-3545.
22. Jimi, E., I. Nakamura, H. Amano, Y. Taguchi, T. Tsurukai, M. Tamura, N. Takahashi, and T. Suda. 1996. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 137: 2187-2190.
23. Kong, Y.-Y., H. Yoshida, I. Sarosi, H.-L. Tan, E. Timms, C. Capparelli, S. Morony, A.J. Oliveria-dos Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315-323.
24. Lacey, D.L., E. Timms, H.-L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176.
25. Lakkakorpi, P.T., and H.K. Väänänen. 1991. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J. Bone Miner. Res. 6:817-826.
26. Lakkakorpi, P., J. Tuukkanen, T. Hentunen, K. Järvelin, K. Väänänen. 1989. Organization of osteoclast microfilaments during the attachment to bone surfaces in vitro. J. Bone Min. Res. 4:817-825.
27. 3, in osteoclasts. J. Cell Science. 104:663-670.
28. Lakkakorpi, P.T., G. Wesolowski, Z. Zimolo, G.A. Rodan, and S.B. Rodan. 1997. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Exp. Cell Res. 237:296-306.
29. Lee, M.Y., D.R. Eyre, and W.R.A. Osborne. 1991. Isolation of a murine osteoclast colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 88:8500-8504.
30. Lowe, C., T. Yoneda, B.F. Boyce, H. Chen, G.R. Mundy, and P. Soriano. 1993. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA. 90:4485-4489.
31. Malgaroli, A., J. Meldolesi, A. Zambonin-Zallone, and A. Teti. 1989. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J. Biol. Chem. 264:14342-14347.
32. Murrills, R.J., L.S. Stein, C.P. Fey, and D.W. Dempster. 1990. The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: An analysis of pit size and the resorption focus. Endocrinology. 127:2648-2653.
33. Murrills, R.J., L.S. Stein, and D.W. Dempster. 1993. Stimulation of bone resorption and osteoclast clear zone formation by low pH: a time-course study. J. Cell. Physiol. 154:511-518.
34. Nakagawa, N., M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, K. Yano, T. Morinaga, and K. Higashio. 1998. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 253:395-400.
35. Nakamura, I., N. Takahashi, T. Sasaki, S. Tanaka, N. Udagawa, H. Murakami, K. Kimura, Y. Kabuyama, T. Kurokawa, T. Suda, and Y. Fukui. 1995. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett. 361:79-84.
36. Nakamura, I., N. Takahashi, T. Sasaki, E. Jimi, T. Kurokawa, and T. Suda. 1996. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J. Bone Miner. Res. 11: 1873-1879.
37. Nakamura, I., T. Sasaki, S. Tanaka, N. Takahashi, E. Jimi, T. Kurokawa, Y. Kita, S. Ihara, T. Suda, and Y. Fukui. 1997. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts. J. Cell. Phys. 172:230-239.
38. Rodan, S.B., and G.A. Rodan. 1997. Integrin function in osteoclasts. J. Endocrinology. 154:S47-S56.
39. Rodan, G.A., and T.J. Martin. 1981. Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif. Tissue Int. 33:349-351.
40. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.-S. Chang, R. Luethy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:309-319.
41. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702.
42. Suda, T., I. Nakamura, E. Jimi, and N. Takahashi. 1997. Regulation of osteoclast function. J. Bone Miner. Res. 12:869-879.
43. Suda, T., N. Takahashi, and T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocrine Rev. 13:66-80.
44. Takahashi, N., H. Yamana, S. Yoshiki, G.D. Roodman, G.R. Mundy, S.J. Jones, A. Boyde, and T. Suda. 1988. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1373-1382.
45. c-src, preferentially on ruffled border membranes. FEBS Letters. 313:85-89.
46. Teti, A., P.C. Marchisio, and A.Z. Zallone. 1991. Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity. Am. J. Physiol. 261:C1-C7.
47. Tsuda, E., M. Goto, S. Michizuki, K. Yano, F. Kobayashi, T. Morinaga, and K. Higashio. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234:137-142.
48. Turksen, K., J. Kanehisa, M. Opas, J.N.M. Heersche, and J.E. Aubin. 1988. Adhesion patterns and cytoskeleton of rabbit osteoclasts on bone slices and glass. J. Bone Miner. Res. 3:389-400.
49. Väänänen, H.K., and M. Horton. 1995. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J. Cell Sci. 108:2729-2732.
50. Wong, B.R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F.S. Bartlett III, W.N. Frankel, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family thai activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194.
51. Wong, B., R. Josien, S. Yu. Lee, M. Vologodskaia, R.M. Steinman, and Y. Choi. 1998. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J. Biol. Chem. 273:28355-28359.
52. Yasuda, Y., N. Shima, N. Nakagawa, S. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, et al. 1998a. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139:1329-1337.
53. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Konosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998b. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:3597-3602.
54. Yoneda, T., I. Kato, L.F. Bonewald, W.H. Burgess, and G.R. Mundy. 1993. A novel cytokine with osteoclastopoietic activity. J. Periodontal Res. 28:521-522.
55. Zaidi, M., H.K. Datta, A. Patchell, B. Moonga, and I. MacIntrye. 1989. Calcium-activated intracellular calcium: a novel mechanism of osteoclast regulation. Biochem. Biophys. Res. Commun. 163:1461-1465.